Merck spends $10 billion for Verona, gaining access to its COPD medication
Read full article: Merck spends $10 billion for Verona, gaining access to its COPD medicationPharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/ANCE4QALKBCDVBOBKQULUPIPB4.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/08-28-2020/t_f6f3250d5cbe436bbbfcd39ae2c2fc6f_name_image.jpg)